Home - Products - Others - Other Targets - 2-Butenoic acid, 2-methyl-, (3aS,4R,6E,10R,11aR)-2,3,3a,4,5,8,9, 10,11,11a-decahydro-6,10-bis(hydroxymethyl)-3-methylene-2-ox ocyc lodeca[b]furan-4-yl ester,(2Z)-

2-Butenoic acid, 2-methyl-, (3aS,4R,6E,10R,11aR)-2,3,3a,4,5,8,9, 10,11,11a-decahydro-6,10-bis(hydroxymethyl)-3-methylene-2-ox ocyc lodeca[b]furan-4-yl ester,(2Z)-

CAS No. 849693-09-0

2-Butenoic acid, 2-methyl-, (3aS,4R,6E,10R,11aR)-2,3,3a,4,5,8,9, 10,11,11a-decahydro-6,10-bis(hydroxymethyl)-3-methylene-2-ox ocyc lodeca[b]furan-4-yl ester,(2Z)-( ——— )

Catalog No. M38389 CAS No. 849693-09-0

Anti-osteoporosis agent-2 (Compound 10) is an anti-osteoporosis agent. Anti-osteoporosis agent-2 inhibits differentiation on osteoclast induced by RANKL.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2-Butenoic acid, 2-methyl-, (3aS,4R,6E,10R,11aR)-2,3,3a,4,5,8,9, 10,11,11a-decahydro-6,10-bis(hydroxymethyl)-3-methylene-2-ox ocyc lodeca[b]furan-4-yl ester,(2Z)-
  • Note
    Research use only, not for human use.
  • Brief Description
    Anti-osteoporosis agent-2 (Compound 10) is an anti-osteoporosis agent. Anti-osteoporosis agent-2 inhibits differentiation on osteoclast induced by RANKL.
  • Description
    Anti-osteoporosis agent-2 (Compound 10) is an anti-osteoporosis agent. Anti-osteoporosis agent-2 inhibits differentiation on osteoclast induced by RANKL.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    849693-09-0
  • Formula Weight
    364.43
  • Molecular Formula
    C20H28O6
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Qiong Gu, et al. Gilmane type sesquiterpene lactone compound and preparation method and application thereof. Patent CN112159378A.
molnova catalog
related products
  • (R)-Omeprazole Sodiu...

    (R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.

  • Allocryptopine

    Allocryptopine has certain effects on anti-injury for hepatocyte, ameliorating liver function, and prohibiting hepatic fibrosis; it increases mRNA levels of cytochromes P450 1A in human hepatocytes and HepG2 cells independently of AhR.

  • N-benzoyltyramine

    The roots of Litsea hypophaea.